No abstract available.
Adult* ; Humans ; Life Style*

BACKGROUND: Interleukin-2 receptor (IL-2) is expressed and released predominantly activated T lymphocyte. Increased serum levels of soluble IL-2R have been noted in a variety of autoimmune diseases and in conditions associated with T lymphocyte activation. OBJECTIVE: We aimed to examine whether the T lymphocyte activation has any association with the pathogenesis of Behçet's disease. METHOD: We have measured the serum level of soluble IL-2R in serum samples obtained from 67 patients with Behçet's disease and 30 healthy people as a control group, using a double-antibody sandwich enzyme-linked immunosorbent assay technique. RESULTS: Serum soluble IL-2R levels were found to be significantly elevated in the group of Behçet's disease as compared with the control group. No significant differences were found within clinical subtypes of Behçet's disease. CONCLUSION: These findings suggest the presence of an ongoing T lymphocyte activation in this disease process.
Autoimmune Diseases ; Enzyme-Linked Immunosorbent Assay ; Humans ; Interleukin-2* ; Lymphocyte Activation ; Lymphocytes ; Methods ; Receptors, Interleukin-2*

BACKGROUND: Interleukin-2 receptor (IL-2) is expressed and released predominantly activated T lymphocyte. Increased serum levels of soluble IL-2R have been noted in a variety of autoimmune diseases and in conditions associated with T lymphocyte activation. OBJECTIVE: We aimed to examine whether the T lymphocyte activation has any association with the pathogenesis of Behçet's disease. METHOD: We have measured the serum level of soluble IL-2R in serum samples obtained from 67 patients with Behçet's disease and 30 healthy people as a control group, using a double-antibody sandwich enzyme-linked immunosorbent assay technique. RESULTS: Serum soluble IL-2R levels were found to be significantly elevated in the group of Behçet's disease as compared with the control group. No significant differences were found within clinical subtypes of Behçet's disease. CONCLUSION: These findings suggest the presence of an ongoing T lymphocyte activation in this disease process.
Autoimmune Diseases ; Enzyme-Linked Immunosorbent Assay ; Humans ; Interleukin-2* ; Lymphocyte Activation ; Lymphocytes ; Methods ; Receptors, Interleukin-2*

No abstract available.
Carcinoma, Hepatocellular* ; Spleen*

No abstract available.
Hematoma*

No abstract available.

No abstract available.
Amebiasis* ; Diabetes Mellitus* ; Humans ; Kidney* ; Liver*

No abstract available.
Kidney* ; Rhabdomyolysis* ; Transplantation*

Polycythemia vera, essential thrombocythemia, and primary myelofibrosis are collectively known as 'Philadelphia-negative classical myeloproliferative neoplasms (MPNs).' The discovery of new genetic aberrations such as Janus kinase 2 (JAK2) have enhanced our understanding of the pathophysiology of MPNs. Currently, the JAK2 mutation is not only a standard criterion for diagnosis but is also a new target for drug development. The JAK1/2 inhibitor, ruxolitinib, was the first JAK inhibitor approved for patients with intermediate- to high-risk myelofibrosis and its effects in improving symptoms and survival benefits were demonstrated by randomized controlled trials. In 2011, the Korean Society of Hematology MPN Working Party devised diagnostic and therapeutic guidelines for Korean MPN patients. Subsequently, other genetic mutations have been discovered and many kinds of new drugs are now under clinical investigation. In view of recent developments, we have revised the guidelines for the diagnosis and management of MPN based on published evidence and the experiences of the expert panel. Here we describe the epidemiology, new genetic mutations, and novel therapeutic options as well as diagnostic criteria and standard treatment strategies for MPN patients in Korea.
Antineoplastic Agents/*therapeutic use ; Asian Continental Ancestry Group/genetics ; Humans ; Janus Kinase 2/*antagonists & inhibitors/genetics/metabolism ; Molecular Targeted Therapy ; Mutation ; Myeloproliferative Disorders/diagnosis/drug therapy/enzymology/ethnology/genetics ; Protein Kinase Inhibitors/*therapeutic use ; Republic of Korea/epidemiology ; Risk Factors ; Signal Transduction/drug effects ; Treatment Outcome

OBJECTIVES: The aims of this study were to examine the prevalence of Attention Deficit Hyperactivity Disorder(ADHD) as well as the relationship between ADHD and related factors among elementary school students living nearby Shihwa-Banwol industrial complex. METHODS: A cross-sectional survey was conducted on 573 elementary students living nearby Shihwa-Banwol industrial complex. Dupaul ADHD rating scales were used for assessment of ADHD. Information on age, gender, birth weight, family history, environmental factors including second-hand smoke, house income, house type, bring up a child, road proximity and behavioral factors including outside activity time, eating habits, and cell phone usage were based on data from self-administered questionnaires. Multiple logistic regression analysis was performed, and all odds ratios were adjusted according to age and gender. RESULTS: The prevalence of ADHD was 9.4%, and those aged 10 years were the most affected. Male elementary school students were 3.19 times (95% CI:1.71~5.93) more likely to have ADHD than females. ADHD was significantly associated with family history of mental disease (adjusted OR 8.69; 95%CI 1.93~39.22), lack of cell phones usage (adjusted OR 2.27; 95%CI 1.21~4.26), a road adjacent to child's residence (adjusted OR 2.21; 95%CI 1.20~4.05) and lack of seafood consumption (adjusted OR 2.08; 95%CI 1.08~4.00). CONCLUSIONS: More research effort should be focused on determining the prevalence of ADHD and relevant factors among children living nearby industrial complexes.
Aged ; Attention Deficit Disorder with Hyperactivity ; Birth Weight ; Cellular Phone ; Child ; Cross-Sectional Studies ; Eating ; Female ; Humans ; Logistic Models ; Male ; Odds Ratio ; Prevalence ; Questionnaires ; Seafood ; Smoke ; Weights and Measures